RVC March 2026 Investor Forum & Happy Hour

RVC March 2026 Investor Forum

Hosted at Thrive Ballpark

RVC Investor Forums bring together accredited angel investors interested in fast-growing, early-stage companies in Colorado. These forums serve to pool the wisdom, expertise, and capital of many individual angels. At this forum, investor members will hear pitches, and afterwards the founders are excused and investors discuss the merits and risks of each venture. There is no requirement to invest and each investor has an opportunity to indicate interest in following or leading a specific deal. Both new and experienced investor members are welcome at forums -- this is the best way to learn hands-on about angel investing! 

Meeting Agenda:

Welcome and Introductions

3:00pm to 3:15 pm

Deal-in-Play Discussion

3:15pm to 3:30pm

3:30 pm to 4:15pm

Investor Only Discussion

4:15 to 5:00pm

Investor Social

5:00 to 6:00pm

Presenting Companies

HapWare is a wearable technology company that makes ALEYE, a wearable that provides people who are blind, low vision and neurodiverse with real time access to nonverbal and social cues.

OncoPatch is a medical device and services company dedicated to advancing non-invasive treatment for skin cancer through Y-90 patch brachytherapy. Designed for use in outpatient dermatology settings, the self-shielded patch delivers targeted radiation to the first few millimeters of skin, providing highly focal treatment while sparing deeper tissues. Because Y-90 is less penetrating than traditional external beam radiation, therapy may be completed in five or fewer sessions. The system requires no major capital equipment purchases or facility renovations, eliminating the need for lead-shielded rooms and enabling seamless integration into dermatology practices. OncoPatch’s integrated care model supports site-of-care alignment, enhances patient convenience, and may improve cost efficiency by shifting appropriate treatments from hospital outpatient departments to office-based care while maintaining radiation oncology oversight and regulatory compliance. This approach expands options for appropriately selected patients while streamlining care.

Manifest Technologies is reimagining the future of manufacturing with its advanced volumetric technology, enabling rapid, high-quality production of complex parts. This sustainable approach surpasses traditional methods, empowering industries to tackle existing challenges and unlock new opportunities that were previously impossible.

To attend this event, you must be accredited: Net worth of at least one million US dollars, not including the value of one’s primary residence, or have made at least $200,000 each year for the last two years [or $300,000 if jointly filing] and have the expectation to make the same amount this year. We do not require a minimum investment.